BreAnna Kinghorn
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
BreAnna Kinghorn has a total of 83 co-authors. Here are the top co-authors by number of shared publications:
Margaret Rosenfeld
Seattle Children's Hospital Seattle Washington USA
6 shared publicationsStephanie D. Davis
UNC Children's, Department of Pediatrics, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, USA
5 shared publicationsErin Sullivan
Seattle Children′s Research Institute, Seattle Children′s Hospital Seattle Washington USA
4 shared publicationsMargaret W. Leigh
Department of Pediatrics University of North Carolina School of Medicine Chapel Hill North Carolina USA
4 shared publicationsCarlos Milla
Department of Pediatrics Stanford University Palo Alto California USA
3 shared publicationsJessica E. Pittman
Department of Pediatrics Washington University School of Medicine St. Louis Missouri USA
3 shared publications
Latest Publications
- Open Access
- 12 November 2025
- Published by Wiley in Pediatric Pulmonology
- Vol. 60 (11) , e71372
New Treatments Are Urgently Needed for Patients With All Primary Ciliary Dyskinesia Genotypes
- 12 November 2025
- Published by Wiley in Pediatric Pulmonology
- Vol. 60 (11) , e71372
Open AccessNew Treatments Are Urgently Needed for Patients With All Primary Ciliary Dyskinesia Genotypes
- 31 October 2025
- Published by Elsevier in Journal of Pediatric Surgery
- Vol. 61 (1) , 162795
Prenatal lung volumes and postnatal lung perfusion in congenital diaphragmatic hernia: A pilot study
- 31 October 2025
- Published by Elsevier in Journal of Pediatric Surgery
- Vol. 61 (1) , 162795
Prenatal lung volumes and postnatal lung perfusion in congenital diaphragmatic hernia: A pilot study
- Top Cited Papers
- 26 September 2025
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 66 (6) , 2500745
European Respiratory Society and American Thoracic Society guidelines for the diagnosis of primary ciliary dyskinesia
Primary ciliary dyskinesia (PCD) is caused by pathogenetic variants in more than 55 genes. PCD is associated with early-onset chronic wet cough and rhinosinusitis, laterality defects, middle ear disease and reduced fertility. The clinical presentation is heterogeneous, and diagnosis often relies on multiple tests. The American Thoracic Society (ATS) and European Respiratory Society (ERS) have previously developed separate guidelines for diagnosis. Here, ERS and ATS members systematically reviewed the literature on diagnostic tools used in practice and developed unified evidence-based guidelines for PCD diagnosis using Grading of Recommendations, Assessment, Development and Evaluations methodology, and a transparent process of decision-making using evidence-to-decision frameworks. The Task Force panel formulated three PICO (Patients, Intervention, Comparison, Outcome) questions and three narrative questions. The accuracies of high-speed video microscopy, immunofluorescence and nasal nitric oxide were compared to a reference test of transmission electron microscopy and/or genetics. The panel gives a strong recommendation for use of high-speed video microscopy, immunofluorescence and nasal nitric oxide as adjunct tests to transmission electron microscopy and/or genetics for PCD diagnosis. However, no adjunct test is suitable as a standalone test to diagnose PCD and no single adjunct or reference test is suitable to exclude PCD. Pursuing a genetic diagnosis is encouraged owing to the implications for management. The panel emphasises that tests should meet a minimum standard and proposes that patients are evaluated at a referral centre experienced in diagnosis. The pre-test probability based on symptoms should be considered when interpreting results.
- 26 September 2025
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 66 (6) , 2500745
Top Cited PapersEuropean Respiratory Society and American Thoracic Society guidelines for the diagnosis of primary ciliary dyskinesia
Primary ciliary dyskinesia (PCD) is caused by pathogenetic variants in more than 55 genes. PCD is associated with early-onset chronic wet cough and rhinosinusitis, laterality defects, middle ear disease and reduced fertility. The clinical presentation is heterogeneous, and diagnosis often relies on multiple tests. The American Thoracic Society (ATS) and European Respiratory Society (ERS) have previously developed separate guidelines for diagnosis. Here, ERS and ATS members systematically reviewed the literature on diagnostic tools used in practice and developed unified evidence-based guidelines for PCD diagnosis using Grading of Recommendations, Assessment, Development and Evaluations methodology, and a transparent process of decision-making using evidence-to-decision frameworks. The Task Force panel formulated three PICO (Patients, Intervention, Comparison, Outcome) questions and three narrative questions. The accuracies of high-speed video microscopy, immunofluorescence and nasal nitric oxide were compared to a reference test of transmission electron microscopy and/or genetics. The panel gives a strong recommendation for use of high-speed video microscopy, immunofluorescence and nasal nitric oxide as adjunct tests to transmission electron microscopy and/or genetics for PCD diagnosis. However, no adjunct test is suitable as a standalone test to diagnose PCD and no single adjunct or reference test is suitable to exclude PCD. Pursuing a genetic diagnosis is encouraged owing to the implications for management. The panel emphasises that tests should meet a minimum standard and proposes that patients are evaluated at a referral centre experienced in diagnosis. The pre-test probability based on symptoms should be considered when interpreting results.
- Open Access
- 18 September 2025
- Published by Wiley in Pediatric Pulmonology
- Vol. 60 (9) , e71287
Airway Disease Progression on Chest Computed Tomography in Children With Primary Ciliary Dyskinesia
Rationale: The longitudinal trajectory of airway disease on chest computed tomography (CT) and risk factors for progression in primary ciliary dyskinesia (PCD) is largely unknown. Methods: Longitudinal analysis of structural airway disease among children with PCD enrolled in a prospective, multicenter observational study, stratified by ultrastructural defect group. CTs were scored utilizing the Melbourne‐Rotterdam Annotated Grid Morphometric Analysis for PCD, evaluating airway abnormalities in a hierarchical order: atelectasis, bronchiectasis (%BE), airway wall thickening, and mucus plugging/tree in bud opacities (%MP). Volume fraction of each component was expressed as % of total lung volume. %Disease (%DIS) is the sum of all components. Mixed effects regression analyses were utilized to describe the association between clinical predictors and CT scores adjusted for relevant covariates. Results: Chest CTs ( N = 424) were obtained from 142 children over a mean (SD) of 4.9 (3.7) years. Mean (SD) age at first CT was 8.5 (4.6) years. Mean %DIS increased with age for the cohort (0.09% per year, 95% CI: 0.02–0.15, p < 0.01), driven by increased %BE (0.06 higher per year, 95% CI: 0.04–0.08, p = 0.0001) and increased odds of MP (1.14 higher odds per year, 95% CI: 1.08–1.21, p < 0.0001). Children with inner dynein arm and microtubular defects had increased mean %DIS and increased odds of MP compared to other ciliary abnormalities (1.73% higher, 95% CI: 0.71–2.74, p = 0.001; 3.21 higher odds per year, 95% CI: 1.73–5.95, p < 0.001). Annual increase in CT scores did not differ between defect groups. Conclusions: Children with PCD experience progressive bronchiectasis and worsening mucus plugging with age.
- 18 September 2025
- Published by Wiley in Pediatric Pulmonology
- Vol. 60 (9) , e71287
Open AccessAirway Disease Progression on Chest Computed Tomography in Children With Primary Ciliary Dyskinesia
Rationale: The longitudinal trajectory of airway disease on chest computed tomography (CT) and risk factors for progression in primary ciliary dyskinesia (PCD) is largely unknown. Methods: Longitudinal analysis of structural airway disease among children with PCD enrolled in a prospective, multicenter observational study, stratified by ultrastructural defect group. CTs were scored utilizing the Melbourne‐Rotterdam Annotated Grid Morphometric Analysis for PCD, evaluating airway abnormalities in a hierarchical order: atelectasis, bronchiectasis (%BE), airway wall thickening, and mucus plugging/tree in bud opacities (%MP). Volume fraction of each component was expressed as % of total lung volume. %Disease (%DIS) is the sum of all components. Mixed effects regression analyses were utilized to describe the association between clinical predictors and CT scores adjusted for relevant covariates. Results: Chest CTs ( N = 424) were obtained from 142 children over a mean (SD) of 4.9 (3.7) years. Mean (SD) age at first CT was 8.5 (4.6) years. Mean %DIS increased with age for the cohort (0.09% per year, 95% CI: 0.02–0.15, p < 0.01), driven by increased %BE (0.06 higher per year, 95% CI: 0.04–0.08, p = 0.0001) and increased odds of MP (1.14 higher odds per year, 95% CI: 1.08–1.21, p < 0.0001). Children with inner dynein arm and microtubular defects had increased mean %DIS and increased odds of MP compared to other ciliary abnormalities (1.73% higher, 95% CI: 0.71–2.74, p = 0.001; 3.21 higher odds per year, 95% CI: 1.73–5.95, p < 0.001). Annual increase in CT scores did not differ between defect groups. Conclusions: Children with PCD experience progressive bronchiectasis and worsening mucus plugging with age.
- 1 December 2024
- Published by Oxford University Press (OUP) in Annals of the American Thoracic Society
- Vol. 21 (12) , 1723-1732
Comparison of Longitudinal Outcomes in Children with Primary Ciliary Dyskinesia and Cystic Fibrosis
Rationale: Primary ciliary dyskinesia (PCD) and cystic fibrosis (CF) are both genetic diseases of mucociliary clearance resulting in progressive lung disease with onset in early life. PCD is often considered to be milder than CF in childhood, based on minimal evidence. Similar to CF, genotype-phenotype associations exist in PCD; pathogenic variants in CCDC39 and CCDC40, causing inner dynein arm/microtubular defects (IDA/MTD), are associated with more severe disease. Objectives: To compare longitudinal outcomes in matched children with PCD and CF. We hypothesized that children with PCD with IDA/MTD defects would have lower lung function but better nutritional indices than matched children with CF with minimal function genotypes (i.e., those associated with pancreatic insufficiency). Methods: Children with PCD enrolled in a prospective, multicenter, observational study were matched with patients with CF from the Cystic Fibrosis Foundation Patient Registry by birth cohort, age, sex, race/ethnicity, and year of study visit. The association of disease group overall and by severity class (PCD-IDA/MTD vs. all other defects and CF-minimal vs. residual function) with longitudinal outcomes up to age 17 was evaluated with cubic spline mixed effects models. Results: Groups included 136 children with PCD (40 IDA/MTD, 96 other) and 476 with CF (446 minimal function, 30 residual function). Below age 14, the PCD group had similar or lower estimated mean forced expiratory volume in 1 second percent predicted compared with CF (e.g., at age 10, -5.4% predicted lower; 95% confidence interval [CI], -7.7, -3.1). Compared with the CF-minimal function (pancreatic insufficient) group, the PCD-IDA/MTD group had similar body mass index; estimated mean forced expiratory volume in 1 second percent predicted was significantly lower by age 10 (mean difference, -10.6%; 95% CI, -14.7, -6.4), increasing at age 14 (mean difference, -15.7%; 95% CI, -20.3, -11.2). The CF cohort had increased prevalence of Pseudomonas aeruginosa cultured on one or more occasions compared with children with PCD (67% vs. 27%; P < 0.001); there was no difference in the prevalence of P. aeruginosa between children with PCD-IDA/MTD and PCD-other. Conclusions: In childhood, average lung function abnormalities in PCD are not milder than CF, particularly for those with IDA/MTD ciliary defects. New guidelines and treatments to improve outcomes in PCD are urgently needed.
- 1 December 2024
- Published by Oxford University Press (OUP) in Annals of the American Thoracic Society
- Vol. 21 (12) , 1723-1732
Comparison of Longitudinal Outcomes in Children with Primary Ciliary Dyskinesia and Cystic Fibrosis
Rationale: Primary ciliary dyskinesia (PCD) and cystic fibrosis (CF) are both genetic diseases of mucociliary clearance resulting in progressive lung disease with onset in early life. PCD is often considered to be milder than CF in childhood, based on minimal evidence. Similar to CF, genotype-phenotype associations exist in PCD; pathogenic variants in CCDC39 and CCDC40, causing inner dynein arm/microtubular defects (IDA/MTD), are associated with more severe disease. Objectives: To compare longitudinal outcomes in matched children with PCD and CF. We hypothesized that children with PCD with IDA/MTD defects would have lower lung function but better nutritional indices than matched children with CF with minimal function genotypes (i.e., those associated with pancreatic insufficiency). Methods: Children with PCD enrolled in a prospective, multicenter, observational study were matched with patients with CF from the Cystic Fibrosis Foundation Patient Registry by birth cohort, age, sex, race/ethnicity, and year of study visit. The association of disease group overall and by severity class (PCD-IDA/MTD vs. all other defects and CF-minimal vs. residual function) with longitudinal outcomes up to age 17 was evaluated with cubic spline mixed effects models. Results: Groups included 136 children with PCD (40 IDA/MTD, 96 other) and 476 with CF (446 minimal function, 30 residual function). Below age 14, the PCD group had similar or lower estimated mean forced expiratory volume in 1 second percent predicted compared with CF (e.g., at age 10, -5.4% predicted lower; 95% confidence interval [CI], -7.7, -3.1). Compared with the CF-minimal function (pancreatic insufficient) group, the PCD-IDA/MTD group had similar body mass index; estimated mean forced expiratory volume in 1 second percent predicted was significantly lower by age 10 (mean difference, -10.6%; 95% CI, -14.7, -6.4), increasing at age 14 (mean difference, -15.7%; 95% CI, -20.3, -11.2). The CF cohort had increased prevalence of Pseudomonas aeruginosa cultured on one or more occasions compared with children with PCD (67% vs. 27%; P < 0.001); there was no difference in the prevalence of P. aeruginosa between children with PCD-IDA/MTD and PCD-other. Conclusions: In childhood, average lung function abnormalities in PCD are not milder than CF, particularly for those with IDA/MTD ciliary defects. New guidelines and treatments to improve outcomes in PCD are urgently needed.
- 1 May 2023
- Published by Oxford University Press (OUP)
- p. A1921
KCNQ1 Gene Defect in a Child With Severe Multi-lobar Bronchiectasis
- 1 May 2023
- Published by Oxford University Press (OUP)
- p. A1921
KCNQ1 Gene Defect in a Child With Severe Multi-lobar Bronchiectasis
- 1 April 2023
- Published by Oxford University Press (OUP) in Annals of the American Thoracic Society
- Vol. 20 (4) , 539-547
Airway Disease in Children with Primary Ciliary Dyskinesia: Impact of Ciliary Ultrastructure Defect and Genotype
Rationale: Primary ciliary dyskinesia (PCD) is characterized by impaired mucociliary clearance, recurrent respiratory infections, progressive airway damage, and obstructive lung disease. Although the association of ciliary ultrastructure defect/genotype with the severity of airflow obstruction has been well characterized, their association with airway abnormalities on chest computed tomography (CT) has been minimally evaluated. Objectives: We sought to delineate the association of ciliary defect class/genotype with chest CT scores in children with PCD. Methods: Cross-sectional analysis of children with PCD (N = 146) enrolled in a prospective multicenter observational study, stratified by defect type: outer dynein arm (ODA), ODA/inner dynein arm (IDA), IDA/microtubular disorganization (MTD), and normal/near normal ultrastructure with associated genotypes. CTs were scored using the MERAGMA-PCD (Melbourne-Rotterdam Annotated Grid Morphometric Analysis for PCD), evaluating airway abnormalities in a hierarchical order: atelectasis, bronchiectasis, bronchial wall thickening, and mucus plugging/tree-in-bud opacities. The volume fraction of each component was expressed as the percentage of total lung volume. The percentage of disease was computed as the sum of all components. Regression analyses were used to describe the association between clinical predictors and CT scores. Results: Acceptable chest CTs were obtained in 141 children (71 male): 57 ODA, 20 ODA/IDA, 40 IDA/MTD, and 24 normal/near normal. The mean (standard deviation) age was 8.5 (4.6) years, forced expiratory volume in 1 second (FEV1) percent predicted was 82.4 (19.5), and %Disease was 4.6 (3.5). Children with IDA/MTD defects had a higher %Disease compared with children with ODA defects (2.71% higher [95% confidence interval (CI), 1.37–4.06; P < 0.001]), driven by higher %Mucus plugging (2.35% higher [1.43–3.26; P < 0.001]). Increasing age, lower body mass index, and lower FEV1 were associated with a higher %Disease (0.23%; 95% CI, 0.11–0.35; P < 0.001 and 0.03%; 95% CI, 0.01–0.04; P = 0.008 and 0.05%; 95% CI, 0.01–0.08; P = 0.011, respectively). Conclusions: Children with IDA/MTD defects had significantly greater airway disease on CT, primarily mucus plugging, compared with children with ODA defects.
- 1 April 2023
- Published by Oxford University Press (OUP) in Annals of the American Thoracic Society
- Vol. 20 (4) , 539-547
Airway Disease in Children with Primary Ciliary Dyskinesia: Impact of Ciliary Ultrastructure Defect and Genotype
Rationale: Primary ciliary dyskinesia (PCD) is characterized by impaired mucociliary clearance, recurrent respiratory infections, progressive airway damage, and obstructive lung disease. Although the association of ciliary ultrastructure defect/genotype with the severity of airflow obstruction has been well characterized, their association with airway abnormalities on chest computed tomography (CT) has been minimally evaluated. Objectives: We sought to delineate the association of ciliary defect class/genotype with chest CT scores in children with PCD. Methods: Cross-sectional analysis of children with PCD (N = 146) enrolled in a prospective multicenter observational study, stratified by defect type: outer dynein arm (ODA), ODA/inner dynein arm (IDA), IDA/microtubular disorganization (MTD), and normal/near normal ultrastructure with associated genotypes. CTs were scored using the MERAGMA-PCD (Melbourne-Rotterdam Annotated Grid Morphometric Analysis for PCD), evaluating airway abnormalities in a hierarchical order: atelectasis, bronchiectasis, bronchial wall thickening, and mucus plugging/tree-in-bud opacities. The volume fraction of each component was expressed as the percentage of total lung volume. The percentage of disease was computed as the sum of all components. Regression analyses were used to describe the association between clinical predictors and CT scores. Results: Acceptable chest CTs were obtained in 141 children (71 male): 57 ODA, 20 ODA/IDA, 40 IDA/MTD, and 24 normal/near normal. The mean (standard deviation) age was 8.5 (4.6) years, forced expiratory volume in 1 second (FEV1) percent predicted was 82.4 (19.5), and %Disease was 4.6 (3.5). Children with IDA/MTD defects had a higher %Disease compared with children with ODA defects (2.71% higher [95% confidence interval (CI), 1.37–4.06; P < 0.001]), driven by higher %Mucus plugging (2.35% higher [1.43–3.26; P < 0.001]). Increasing age, lower body mass index, and lower FEV1 were associated with a higher %Disease (0.23%; 95% CI, 0.11–0.35; P < 0.001 and 0.03%; 95% CI, 0.01–0.04; P = 0.008 and 0.05%; 95% CI, 0.01–0.08; P = 0.011, respectively). Conclusions: Children with IDA/MTD defects had significantly greater airway disease on CT, primarily mucus plugging, compared with children with ODA defects.
- 1 September 2020
- Published by Oxford University Press (OUP) in Annals of the American Thoracic Society
- Vol. 17 (9) , 1085-1093
Comparison of Multiple Breath Washout and Spirometry in Children with Primary Ciliary Dyskinesia and Cystic Fibrosis and Healthy Controls
Rationale: In cystic fibrosis (CF), the lung clearance index (LCI), derived from multiple breath washout (MBW), is more sensitive in detecting early lung disease than FEV1; MBW has been less thoroughly evaluated in young patients with primary ciliary dyskinesia (PCD). Objectives: Our objectives were 1) to evaluate the sensitivity of MBW and spirometry for the detection of mild lung disease in young children with PCD and CF compared with healthy control (HC) subjects and 2) to compare patterns of airway obstruction between disease populations. Methods: We used a multicenter, single-visit, observational study in children with PCD and CF with a forced expiratory volume in 1 second (FEV1) greater than 60% predicted and HC subjects, ages 3–12 years. Nitrogen MBW and spirometry were performed and overread for acceptability. χ2 and Kruskall-Wallis tests compared demographics and lung function measures between groups, linear regression evaluated the effect of disease state, and Spearman’s rank correlation coefficient compared the LCI and spirometric measurements. Results: Twenty-five children with PCD, 49 children with CF, and 80 HC children were enrolled, among whom 17 children with PCD (68%), 36 children with CF (73%), and 53 (66%) HC children performed both acceptable spirometry and MBW; these children made up the analytic cohort. The median age was 9.0 years (interquartile range [IQR], 6.8–11.1). The LCI was abnormal (more than 7.8) in 10 of 17 (59%) patients with PCD and 21 of 36 (58%) patients with CF, whereas FEV1 was abnormal in three of 17 (18%) patients with PCD and six of 36 (17%) patients with CF. The LCI was significantly elevated in patients with PCD and CF compared with HC subjects (ratio of geometric mean vs. HC: PCD 1.27; 95% confidence interval [CI], 1.15–1.39; and CF 1.24; 95% CI, 1.15–1.33]). Children with PCD had lower midexpiratory-phase forced expiratory flow % predicted compared with children with CF (62% [IQR, 50–78%] vs. 85% [IQR, 68–99%]; P = 0.05). LCI did not correlate with FEV1. Conclusions: The LCI is more sensitive than FEV1 in detecting lung disease in young patients with PCD, similar to CF. LCI holds promise as a sensitive endpoint for the assessment of early PCD lung disease.
- 1 September 2020
- Published by Oxford University Press (OUP) in Annals of the American Thoracic Society
- Vol. 17 (9) , 1085-1093
Comparison of Multiple Breath Washout and Spirometry in Children with Primary Ciliary Dyskinesia and Cystic Fibrosis and Healthy Controls
Rationale: In cystic fibrosis (CF), the lung clearance index (LCI), derived from multiple breath washout (MBW), is more sensitive in detecting early lung disease than FEV1; MBW has been less thoroughly evaluated in young patients with primary ciliary dyskinesia (PCD). Objectives: Our objectives were 1) to evaluate the sensitivity of MBW and spirometry for the detection of mild lung disease in young children with PCD and CF compared with healthy control (HC) subjects and 2) to compare patterns of airway obstruction between disease populations. Methods: We used a multicenter, single-visit, observational study in children with PCD and CF with a forced expiratory volume in 1 second (FEV1) greater than 60% predicted and HC subjects, ages 3–12 years. Nitrogen MBW and spirometry were performed and overread for acceptability. χ2 and Kruskall-Wallis tests compared demographics and lung function measures between groups, linear regression evaluated the effect of disease state, and Spearman’s rank correlation coefficient compared the LCI and spirometric measurements. Results: Twenty-five children with PCD, 49 children with CF, and 80 HC children were enrolled, among whom 17 children with PCD (68%), 36 children with CF (73%), and 53 (66%) HC children performed both acceptable spirometry and MBW; these children made up the analytic cohort. The median age was 9.0 years (interquartile range [IQR], 6.8–11.1). The LCI was abnormal (more than 7.8) in 10 of 17 (59%) patients with PCD and 21 of 36 (58%) patients with CF, whereas FEV1 was abnormal in three of 17 (18%) patients with PCD and six of 36 (17%) patients with CF. The LCI was significantly elevated in patients with PCD and CF compared with HC subjects (ratio of geometric mean vs. HC: PCD 1.27; 95% confidence interval [CI], 1.15–1.39; and CF 1.24; 95% CI, 1.15–1.33]). Children with PCD had lower midexpiratory-phase forced expiratory flow % predicted compared with children with CF (62% [IQR, 50–78%] vs. 85% [IQR, 68–99%]; P = 0.05). LCI did not correlate with FEV1. Conclusions: The LCI is more sensitive than FEV1 in detecting lung disease in young patients with PCD, similar to CF. LCI holds promise as a sensitive endpoint for the assessment of early PCD lung disease.
- 1 August 2019
- Published by Elsevier in Academic Pediatrics
- Vol. 19 (6) , 631-637
Socioeconomic and Environmental Risk Factors for Pediatric Asthma in an American Indian Community
- 1 August 2019
- Published by Elsevier in Academic Pediatrics
- Vol. 19 (6) , 631-637
Socioeconomic and Environmental Risk Factors for Pediatric Asthma in an American Indian Community
- 16 October 2018
- Published by Wiley in Pediatric Pulmonology
- Vol. 53 (12) , 1662-1669
Clinical course of chronic suppurative lung disease and bronchiectasis in Alaska Native children
Introduction: Alaska Native (AN) children from the Yukon Kuskokwim (YK) Delta region have high rates of chronic suppurative lung disease (CSLD), including bronchiectasis. We characterized the clinical progress of an AN adolescent cohort with CSLD/bronchiectasis, and estimated bronchiectasis prevalence trends in this region.Methods: The original cohort comprised 41 AN children (originally aged 0.5‐8 years) with CSLD/bronchiectasis, recruited between 2005 and 2008, with follow‐up in 2015‐2016. Clinical assessments, lung function, radiography, medical chart review, and spirometry were obtained. We also conducted data queries of bronchiectasis diagnoses in YK individuals born between 1990 and 2010 to estimate prevalence.Results: Thirty‐four (83%) of the original cohort aged 7.3‐17.6 years were reviewed, of whom 14 (41%) had high‐resolution computed tomography (HRCT)‐confirmed bronchiectasis, eight (24%) had no evidence of bronchiectasis on HRCT scans, while 12 (35%) had not undergone HRCT scans. Annual lower respiratory tract infection (LRTI) frequency decreased with age, although 27 (79%) still had respiratory symptoms, including all with HRCT‐confirmed bronchiectasis, who were also more likely than those without confirmed bronchiectasis to have recent wheeze (80 vs 25%, P = 0.005), auscultatory crackles (60 vs 0%, P < 0.001), and lower mean forced expiratory volume in 1‐second/forced vital capacity ratio (73 vs 79%, P = 0.03). The bronchiectasis prevalence for YK AN people born during 2000‐2009 was 7 per 1000 births, which was lower than previously reported.Conclusion: Despite reduced LRTI frequency, most AN children with CSLD/bronchiectasis had symptoms/signs of underlying lung disease as they entered adolescence. Close clinical follow‐up remains essential for managing these patients as they transition to adulthood.
- 16 October 2018
- Published by Wiley in Pediatric Pulmonology
- Vol. 53 (12) , 1662-1669
Clinical course of chronic suppurative lung disease and bronchiectasis in Alaska Native children
Introduction: Alaska Native (AN) children from the Yukon Kuskokwim (YK) Delta region have high rates of chronic suppurative lung disease (CSLD), including bronchiectasis. We characterized the clinical progress of an AN adolescent cohort with CSLD/bronchiectasis, and estimated bronchiectasis prevalence trends in this region.Methods: The original cohort comprised 41 AN children (originally aged 0.5‐8 years) with CSLD/bronchiectasis, recruited between 2005 and 2008, with follow‐up in 2015‐2016. Clinical assessments, lung function, radiography, medical chart review, and spirometry were obtained. We also conducted data queries of bronchiectasis diagnoses in YK individuals born between 1990 and 2010 to estimate prevalence.Results: Thirty‐four (83%) of the original cohort aged 7.3‐17.6 years were reviewed, of whom 14 (41%) had high‐resolution computed tomography (HRCT)‐confirmed bronchiectasis, eight (24%) had no evidence of bronchiectasis on HRCT scans, while 12 (35%) had not undergone HRCT scans. Annual lower respiratory tract infection (LRTI) frequency decreased with age, although 27 (79%) still had respiratory symptoms, including all with HRCT‐confirmed bronchiectasis, who were also more likely than those without confirmed bronchiectasis to have recent wheeze (80 vs 25%, P = 0.005), auscultatory crackles (60 vs 0%, P < 0.001), and lower mean forced expiratory volume in 1‐second/forced vital capacity ratio (73 vs 79%, P = 0.03). The bronchiectasis prevalence for YK AN people born during 2000‐2009 was 7 per 1000 births, which was lower than previously reported.Conclusion: Despite reduced LRTI frequency, most AN children with CSLD/bronchiectasis had symptoms/signs of underlying lung disease as they entered adolescence. Close clinical follow‐up remains essential for managing these patients as they transition to adulthood.